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Effects of endocrine disrupting chemicals on expression of phospholipid 
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Phospholipid hydroperoxide glutathione peroxidase
(PHGPx), an antioxidative selenoprotein, is modulated by
estrogen in the testis and oviduct. To examine whether
potential endocrine disrupting chemicals (EDCs) affect
the microenvironment of the testes, the expression patterns
of PHGPx mRNA and histological changes were analyzed
in 5-week-old Sprague-Dawley male rats exposed to several
EDCs such as an androgenic compound [testosterone (50,
200, and 1,000 µg/kg)], anti-androgenic compounds [flutamide
(1, 5, and 25 mg/kg), ketoconazole (0.2 and 1 mg/kg), and
diethylhexyl phthalate (10, 50, and 250 mg/kg)], and
estrogenic compounds [nonylphenol (10, 50, 100, and 250
mg/kg), octylphenol (10, 50, and 250 mg/kg), and diethyl-
stilbestrol (10, 20, and 40 µg/kg)] daily for 3 weeks via oral
administration. Mild proliferation of germ cells and
hyperplasia of interstitial cells were observed in the testes
of the flutamide-treated group and deletion of the
germinal epithelium and sloughing of germ cells were
observed in testes of the diethylstilbestrol-treated group.
Treatment with testosterone was shown to slightly decrease
PHGPx mRNA levels in testes by the reverse transcription-
polymerase chain reaction. However, anti-androgenic
compounds (flutamide, ketoconazole, and diethylhexyl
phthalate) and estrogenic compounds (nonylphenol,
octylphenol, and diethylstilbestrol) significantly up-
regulated  PHGPx mRNA in the testes (p < 0.05). These
findings indicate that the EDCs might have a detrimental
effect on spermatogenesis via abnormal enhancement of
PHGPx expression in testes and that PHGPx is useful as a
biomarker for toxicity screening of estrogenic or anti-
androgenic EDCs in testes.
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Introduction
Phospholipid hydroperoxide glutathione peroxidase
(PHGPx) is an intracellular antioxidant that belongs to the
superfamily of selenium-dependent peroxidases. It interacts
directly with peroxidized phospholipid and cholesterol and
cholesteryl ester, even when they are incorporated into
biomembranes and lipoproteins [13,31,35]. There are three
different isoforms of PHGPx (cytosolic, mitochondrial, and
nuclear), all derived from a single gene [15]. PHGPx is
widely expressed and its enzymatic activity has been detected
in a variety of tissues, particularly in the endocrine organs
including the testis [5]. PHGPx gene expression and
enzymatic activity are hormone-dependent. PHGPx activity
is influenced by testosterone levels during spermatogenesis
[19]. In rat testes, PHGPx is preferentially expressed after
puberty. Although PHGPx is essentially absent following
hypophysectomy, it can be partially restored by treatment
with human chorionic gonadotropin or testosterone [29].
A variety of structurally diverse natural and synthetic
chemicals, called endocrine disrupting chemicals (EDCs),
have been reported to interfere with the endocrine system.
At the cellular level, EDCs can induce ‘endocrine disruption’
via a number of routes that involve steroid-receptor binding
(agonists), blocking of steroid-receptor binding (antagonists),
or disruption of the biosynthesis and metabolism of steroids
[30]. Estrogenic and androgenic chemicals with similar
structures to estrogen and androgen bind to estrogen receptors
(ERs) or the androgen receptor (AR) and ultimately alter the
normal function of tissues and organs [16]. ERs and AR are
expressed in a cell-specific manner in male and female
reproductive organs [27]. Many studies have reported the
detrimental effects of EDCs on the development of
reproductive organs. Recently, we have demonstrated that
the expression of 3β-hydroxysteroid dehydrogenase, a
histochemical marker for Leydig cells in the testes, can be
affected by treatment with various EDCs [14]. The
administration of vinclozolin, an AR antagonist, during
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sexual differentiation demasculinizes and feminizes male rat
offspring, such that the treated males display a female-like
anogenital distance at birth, retained nipples, hypospadias,
suprainguinal ectopic testes, a blind vaginal pouch, and
small-to-absent sex-accessory glands [11]. Neonatal injection
of vinclozolin at 200 mg/kg/day demasculinized aggressive
play behavior in male rats at 35 days-of-age, indicating that
sexual differentiation was altered in an anti-androgenic manner
[12]. These findings suggest that reproductive organs are
highly susceptible to EDC exposure during organ development
and sexual differentiation and that EDCs have the potential
to perturb steroidogenesis in testes.
Brigelius-Flohe et al. [6] reported that the porcine PHGPx
gene contains a variety of putative regulatory elements,
including estrogen-, progesterone-, and glucorticoid-responsive
sequences [6]. Recently, it was reported that PHGPx
expression and enzymatic activity are up-regulated by
estradiol in the female reproductive tract [17]. We have
previously demonstrated that estradiol can increase PHGPx
mRNA expression in male reproductive organs [23]. In this
study, we examine whether potential anti-androgenic or
estrogenic EDCs affect spermatogenesis, by analyzing
PHGPx mRNA expression and histopathological changes in
testes of rats exposed to various EDCs.
Materials and Methods
EDC treatments
Four-week-old male Sprague-Dawley rats were purchased
from Samtaco (Korea) and acclimated in polycarbonate
cages for 1 week. The animals (n = 10/group) were housed
in an environmentally controlled room with a 12-h light/
dark cycle, temperature of 21 ± 2
oC, and frequent ventilation
at 10 times/h. The animals were fed standard rat chow
(Samyang, Korea) and tap water ad libitum throughout the
experimental period. Testosterone propionate (50, 200, and
1,000 µg/kg), flutamide (FM; 1, 5, and 25 mg/kg), diethylhexyl
phthalate (DEHP; 10, 50, and 250 mg/kg), ketoconazole
(KC; 0.2 and 1 mg/kg), octylphenol (OP; 10, 50, and 250
mg/kg), nonylphenol (NP; 10, 50, 100, and 250 mg/kg), or
diethylstilbestrol (DES; 10, 20, and 40 µg/kg) were orally
administered to the rats daily for 3 weeks. All chemicals
were obtained from Sigma (USA). Control animals received
corn oil (the vehicle) for the same period. All animal
experiments were conducted in compliance with ‘Guide for
Care and Use of Animals’ (Chungbuk National University
Animal Care Committee, according to NIH #86-23).
Histological examination
The rats were euthanized at 8 weeks-of-age under
pentobarbital anesthesia and their testes were rapidly
removed. Testes were fixed in Bouin’s fixative, dehydrated
with increasing concentrations of ethyl alcohol, cleared in
xylene, infiltrated with paraffin and paraplast with an
automatic tissue processor (Shandon, USA), and embedded
in paraffin wax with an embedding machine (Leica,
Germany). The tissue blocks were cut into 5-µm thicknesses
with a rotary microtome (Leica, Germany), stained with
hematoxylin and eosin, and observed under a light microscope
(Leica, Germany).
Total RNA extraction and RT-PCR
Total RNA was extracted from testes using a TRIzol
reagent (Invitrogen, USA) according to the manufacturer’s
instructions. The RNA pellet obtained in the final step was
dissolved in 50 µl of sterile diethylpyrocarbonate (DEPC)-
treated water, and its concentration was determined using a
UV spectrophotometer at 260 nm. RNA was kept in DEPC-
treated water at −70
oC until use. Total RNA (5 µg) was
reverse transcribed using pd(N)6 primers and first-strand
cDNA synthesis reagents (Amersham Biosciences, UK).
The following primer sets were used to amplify PHGPx
(accession number: NM_008162, S1-As2 fragment; 461 bp)
and  beta-actin (accession number: NM_007393, S1-As2







The PCR products were separated on a 2%-agarose gel in
Tris-borate-EDTA buffer. Results were analyzed with an
AlphaEase V5.5 analyzer system (Alpha Innotech, USA).
Statistical analysis
The data were analyzed by analysis of variance and
Duncan’s test as a post-hoc analysis, using the SPSS
software (p < 0.05). All data were presented as means ± SD.
Results
Histological findings
The seminiferous tubules in the testosterone-, OP-, NP-,
DEHP-, and KC-treated groups showed a normal morphology
as well as the control group (Fig. 1A, B & D). However in
the testes from the FM-treated group, mild proliferation of
germ cells and hyperplasia of interstitial cells were observed
(Fig. 1C). In addition, deletion of germinal epithelium and
sloughing of germ cells were observed in the group treated
with 40 µg/kg/day DES (Fig. 1E & F).
Effect of EDCs on PHGPx mRNA expression
The detrimental effects of EDCs on rat testes were studied
using PHGPx mRNA expression as a biomarker. Treatment
with EDCs other than testosterone resulted in a general
increase in PHGPx expression. The testosterone treatment
slightly decreased the PHGPx mRNA levels, but the levelsChanges in PHGPx expression in testes by EDC treatment 215
were not significantly different from the control (Fig. 2).
The expression of PHGPx mRNA in testes was increased in
a dose-dependent manner by FM treatment and was
significantly increased to 194% of the control in rats treated
with 25 mg/kg/day FM (p < 0.05; Fig. 3). In the DEHP-
treated groups, PHGPx mRNA was increased to 113-137%
of the control level (Fig. 4). In the KC-treated groups,
PHGPx mRNA was significantly increased to 147-150% of
the control (p < 0.05; Fig. 5). OP caused the up-regulation of
PHGPx mRNA by more than 37% of the control level (Fig.
6). NP stimulated PHGPx mRNA expression in the testes at
all doses. In particular, the level was significantly increased
to 158% of the control level in the groups treated with 50
and 250 mg/kg/day NP (p < 0.05; Fig. 7). The testicular
level of PHGPx mRNA in the rats exposed to various
concentrations (10, 20, and 40 µg/kg/day) of DES was
significantly higher (154-248%) than that of the control
group (p < 0.05; Fig. 8).
Discussion
Although several putative estrogen-responsive elements
Fig. 1. Histological findings in the testes of 8-week-old rats
treated with the vehicle alone (A), testosterone (1,000 µg/kg)
(B), flutamide (25 mg/kg) (C), diethylhexyl phthalate (250 mg /
kg) (D), or diethylstilbestrol (40 µg/kg) (E & F), daily for 3
weeks by oral administration. H&E stain, A-E; ×100, F; ×200.
Fig. 2. Analysis of expression levels of PHGPx mRNA in the
testes of testosterone-treated rats using reverse transcription-
polymerase chain reaction. β-actin: an intrinsic control. The
values represent mean ± SD.
Fig. 3. Expression pattern of PHGPx mRNA in the testes of
flutamide-treated rats using reverse transcription-polymerase chai n
reaction.  β-actin: an intrinsic control. The values represent
mean ± SD. *Significantly different from the control at  p <0 . 0 5 .
Fig. 4. Investigation of expression levels of PHGPx mRNA in
the testes of diethylhexyl phthalate-treated rats using revers e
transcription-polymerase chain reaction. β-actin: an intrinsic
control. The values represent mean ± SD.216 In-Jeoung Baek et al.
have been located within the 5'-untranslated region and the
first intron of porcine PHGPx [6], the cellular mechanisms
that mediate the action of estrogen on PHGPx regulation
require further inquiry. We previously reported that PHGPx
mRNA expression in male reproductive organs of rats is
greatly influenced by treatment with estradiol or tamoxifen
[23]. PHGPx expression in oviducts is also up-regulated by
estradiol [17]. Based on this previous evidence, we investigated
the expression patterns of PHGPx mRNA and morphological
changes in rat testes after treatment with various EDCs,
including testosterone, anti-androgenic compounds (FM,
KC, and DEHP), and estrogenic compounds (NP, OP, and
DES). Our results indicate that estrogenic or anti-androgenic
EDCs might have a detrimental effect on spermatogenesis
via the abnormal enhancement of PHGPx expression in
testes.
In adult males, fertility and sexual functions are androgen-
dependent. The role of androgens such as testosterone and
their action mechanism in reproduction are well-established.
In testes, the AR is localized in nuclei of cells such as Sertoli
cells, Leydig cells, and peritubular myoid cells [27]. In
mouse testes, PHGPx mRNA is first expressed at 3 weeks-
of-age, greatly increases at 8 weeks, and persists at a high
level until 80 weeks. According to in situ analysis, PHGPx
mRNA is expressed stage-specifically in spermatogenic
cells and Leydig cells [24]. In the present study, treatment
with testosterone (50, 200 and 1,000 µg/kg/day) slightly
decreased  PHGPx mRNA expression in testes. Anti-
androgens have the potential to perturb male reproductive
development and function in humans and experimental
animals and they can act via disturbance of the pituitary-
gonadal axis [3,11,18,22]. FM blocks the negative feedback
of testosterone in the hypothalamus and pituitary and
induces over-expression of steroidogenic enzymes in the
Fig. 5. Expression levels of PHGPx mRNA in the testes of
ketoconazole-treated rats. β-actin: an intrinsic control. The values
represent mean ± SD. *Significantly different from the control a t
p <0 . 0 5 .
Fig. 6. Analysis of expression levels of PHGPx mRNA in the testes
of octylphenol-treated rats using reverse transcription-polymerase
chain reaction. β-actin: an intrinsic control. The values represent
mean ± SD.
Fig. 7. RT-PCR amplification of PHGPx mRNA in the testes.
Rats were treated with nonylphenol for 3 weeks per oral.  β-actin:
an intrinsic control. The values represent means ± SD. *Significantl y
different from the control at p <0 . 0 5 .
Fig. 8. Expression pattern of PHGPx mRNA in the testes
exposed to diethylstilbestrol as measured by RT-PCR.  β-actin: an
intrinsic control. The values represent mean ± SD. *Significantl y
different from the control at p <0 . 0 5 .Changes in PHGPx expression in testes by EDC treatment 217
testis by increasing testosterone production [33]. Ohsako  et
al. [25] reported that serum and testicular testosterone levels
were significantly elevated by the administration of FM
[25]. In this study, the expression level of PHGPx mRNA
was increased by FM treatment (1-25 mg/kg/day) in a dose-
dependent manner. Moreover, mild proliferation of germ
cells and hyperplasia of Leydig cells were induced by
treatment with FM. These results suggest that PHGPx might
be intimately involved in the proliferation of spermatogenic
cells through the synthesis of androgen in Leydig cells.
In our study, treatment with DEHP (10-250 mg/kg/day)
slightly increased PHGPx mRNA expression in testes.
Phthalates, including DEHP, are widely used as a plasticizer
in the production of plastics. In mammals, DEHP treatment
produces developmental and/or reproductive toxicity with a
period of susceptibility extending from the fetal to pubertal
stages-of-life and induces reproductive-tract malformations
in androgen-dependent tissues in male rat offspring [26].
Unlike FM, DEHP does not interact with the AR. Rather,
the effects observed in rodents have been associated with a
reduction in testosterone synthesis by the fetal testis
[9,22,26]. Phthalate treatment interferes with the transcription
of several key genes involved in both cholesterol transport
and the biosynthesis of testosterone [2,32]. In contrast, KC,
a broad-spectrum imidazole antimycotic agent, interferes
with the cytochrome P-450 enzyme system and can cause
inhibition of microsomal steroidogenesis in Leydig cells
[1,21]. In this study, PHGPx mRNA expression was significantly
increased (p < 0.05) to 147-150% of the control level in the
KC-treated group. These findings indicate that the anti-
androgens DEHP and KC induce dysfunction of Leydig
cells and stimulation of PHGPx transcription in testes.
There are two types of ERs, ERα and ERβ, which differ
in the C-terminal ligand-binding domain and the N-terminal
transactivation domain. In testes, ERα is localized in nuclei
of Leydig cells, spermatocytes, and round spermatids. ER β
is detected in spermatogenic cells of various stages and in
Sertoli cells, suggesting that estrogens directly affect germ
cells during testicular development and spermatogenesis
[27]. Alkylphenol ethoxylates are widely used as surfactants
throughout the world. Their metabolites (NP, OP) are
ubiquitous in the environment [10]. OP has been shown to
decrease the expression of steroidogenesis factor-1 mRNA
in the fetal testis [20]. It has also been found to bind to the
ER and to be weakly estrogenic in vitro [34]. NP is also a
weakly estrogenic compound. Several studies have reported
the adverse effects of NP on the development of the male
reproductive tract [4]. In this study, treatment with OP and
NP stimulated PHGPx mRNA expression in testes at all
doses. In particular, the signal was significantly increased by
50 or 250 mg/kg/day NP treatment. These results show that
the alkylphenolic compounds stimulate the expression of
PHGPx  mRNA in a pattern similar to that found in our
previous estradiol-treatment study [14]. DES is a nonsteroidal
synthetic estrogen that has been used to prevent miscarriage
and premature birth. According to in vivo knockout studies,
DES acts through an ERα-mediated mechanism in the male
and female reproductive tracts [7,8,28]. In this study,
PHGPx mRNA in the testis was significantly up-regulated
at various concentrations (10, 20, and 40 µg/kg/day) of
DES. In addition, deletion of germinal epithelium and
sloughing of germ cells in the testes were detected following
DES treatment. These results suggest that, like endogenous
estrogen, environmental estrogenic compounds might stimulate
PHGPx expression in testes via the ER pathway.
In conclusion, we demonstrate that anti-androgenic and
estrogenic EDCs enhance expression of PHGPx mRNA in
the testes, suggesting that PHGPx is useful as a biomarker to
screen for detrimental effects of exogenous EDCs in testes.
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